Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

06. Juillet 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2806


	Articles 1 - 20 / 56109

	Multi-omics integration and machine learning uncover molecular basal-like subtype of pancreatic cancer and implicate A2ML1 in promoting tumor epithelial-mesenchymal transition. J Transl Med Ge J, Cai J, Zhang G, Li D, Tao L. PMID: 40615919 [PubMed - indexed for MEDLINE]
	mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities. Discov Oncol Lv Z, Dai Y. PMID: 40615758 [PubMed]
	Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis. Commun Biol McDonald PC, Topham JT, Awrey S, Tavakoli H, Carroll R, Brown WS, Gerbec ZJ, Kalloger SE, Karasinska JM, Tang P, Goodwin R, Jones SJM, Laskin J, Marra MA, Morin GB, Renouf DJ, Schaeffer DF, Dedhar S. PMID: 40615661 [PubMed - indexed for MEDLINE]
	Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study. Signal Transduct Target Ther Sheng J, Luo H, Liu X, Liu C, Zhou W, Zhao Y, Liu R, Li D, Xu C, Yang B, Liu Y, Fu X, Bao L, Wang K, Hao J, Liu W. PMID: 40615377 [PubMed - indexed for MEDLINE]
	Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol. BMJ Open Chhajlani S, Kuiper J, Beutels P, Borbath I, Dercksen W, Deroose CM, Heemskerk S, Polinder S, Roelant E, Smits E, Verhaegen I, Van der Massen I, Walenkamp A, de Herder WW, Peeters M, Hofland J, Vandamme T, SAUNA investigators and the Dutch Belgian Neuroendocrine Tumor Society (DBNETS). PMID: 40615151 [PubMed - indexed for MEDLINE]
	Prospective Phase II Clinical Trial of Carbon Ion Radiotherapy Combined with Chemotherapy for Locally Advanced Pancreatic Carcinoma. Int J Radiat Oncol Biol Phys Zhang G, Cai X, Cao H, Yu Z, Wang W, Xing Y, Zhao J, Zhang Q, Zhang B, Liang F, Ahmed MM, Wu X, Guha C, Jiang GL, Wang Z. PMID: 40614787 [PubMed - as supplied by publisher]
	Clinicopathological and prognosis analysis of intraductal papillary neoplasm of the bile duct: A dual-center retrospective study. Eur J Surg Oncol Huang X, Zhang Z, Zhu D, Li C, Gao Z, Zhang Z, Guo X, Zhang J, Lu G, Guo T, Yu Y. PMID: 40614341 [PubMed - as supplied by publisher]
	Biomarkers for Early Detection of Pancreatic Cancer. Visc Med Bengtsson A, Andersson R, Linders J, Gulla A, Ansari D. PMID: 40612538 [PubMed - as supplied by publisher]
	The role of JPT1 in hepatocellular carcinoma: tumor progression, microtubule dynamics regulation, and potential mechanisms within the immune microenvironment. Discov Oncol Lu Y, Xu P, Li S, Yao J. PMID: 40610765 [PubMed]
	Evaluation of CEMIP in diagnosis of pancreatic carcinoma in comparison with other traditional markers. Sci Rep Zohne RAE, Zaid AKMA, Moneim OAE, Soliman AM, Safwat DM, Eltokhy SA. PMID: 40610532 [PubMed - indexed for MEDLINE]
	Renal cell carcinoma with metastasis to the pancreas: a model for oligometastasis, oligoprogression and metastatic organotropism. Clin Exp Metastasis Søreide K, Hauge EM, Vigmostad MN. PMID: 40608152 [PubMed - indexed for MEDLINE]
	The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection. Front Immunol Peng N, Mao LF, Su JY, Liu SP, Ou JJ, Chen SC, Su Z, Li WF, Yang FQ, Zhou YH, Li L, Zhong JH. PMID: 40607378 [PubMed - indexed for MEDLINE]
	Essential Update 2023/2024: Multidisciplinary Treatment for Invasive Intraductal Papillary Mucinous Carcinoma. Ann Gastroenterol Surg Hirono S. PMID: 40607299 [PubMed]
	Cost-effectiveness analysis of postoperative surveillance for stage IV colorectal cancer in Japan: An economic modeling study. Ann Gastroenterol Surg Tsukamoto F, Tsukamoto S, Kato T, Nagata H, Takamizawa Y, Moritani K, Kinugasa Y, Esaki M, Kanemitsu Y, Igarashi A. PMID: 40607285 [PubMed]
	Targeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications. Front Pharmacol Li CL, Yao ZY, Sun A, Cao JY, Wang ZS. PMID: 40606603 [PubMed]
	Structure-based discovery and experimental validation of HIT101481851 as a potential PKMYT1 inhibitor for pancreatic cancer. Front Pharmacol Wang T, Wang J, Yao G, Zhang H, Song C, Ao X. PMID: 40606600 [PubMed]
	Trajectories of Î±-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study. BMC Cancer Zheng Y, Hu J, Mei Y, Xiang Y, Lu H, Zhu J, Pan K, Cheng S, Liu Y. PMID: 40604723 [PubMed - indexed for MEDLINE]
	Pancreatic surgery is safe in elderly patients with PDAC. BMC Geriatr Zhang Y, Han S, Xu Y, Liu L, Wu W, Zhang L, Shi C, Song C, Wang D, Lou W. PMID: 40604566 [PubMed - indexed for MEDLINE]
	Large language model trained on clinical oncology data predicts cancer progression. NPJ Digit Med Zhu M, Lin H, Jiang J, Jinia AJ, Jee J, Pichotta K, Waters M, Rose D, Schultz N, Chalise S, Valleru L, Morin O, Moran J, Deasy JO, Pilai S, Nichols C, Riely G, Braunstein LZ, Li A. PMID: 40604229 [PubMed]
	Iron and Cancer. Adv Exp Med Biol Torti SV, Tesfay L, Torti FM. PMID: 40603797 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 56109

Page 1 de 2806



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité